Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oberweis Micro-Cap Fund (OBMCX)

14.80
Net Asset Value
-4.76%
1 Day
-16.29%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.71%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize capital appreciation. The fund invests, under normal circumstances, at least 80% of its net assets in the securities of very small companies which, at the time of purchase, have a market capitalization of less than or equal to $600 million or are within the range of companies represented in the Russell Micro-Cap Growth Index. It invests principally in the common stocks of companies that the fund's investment adviser believes have the potential for significant long-term growth in market value.

Performance

1 month-13.85% 3 years+8.39%
3 months-19.16% 5 years+5.48%
1 year-9.20% Since inception+8.56%
Data through --

Peer Comparisonvs. Small growth

 OBMCXCategory
Performance 5-yr return+5.48%+9.40%
Expense ratio1.71%1.35%
Risk 5 year sharpe ratio0.500.49
Net assets$48.7M$756.9M
Average market cap$564.1M$2.8B
Average P/E25.524.3
Portfolio turnover141%141%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOberweis
Fund manager & tenureJames Oberweis / 14 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock99.03%
Fixed income0.73%
International stock0.24%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Hardware 22.00%
Industrial materials 14.68%
Business service 10.58%
Consumer goods 9.74%
Healthcare 8.79%
Top 10 Holdings
Portfolio weighting
IPHI Inphi Corp2.80%
MXL MaxLinear Inc2.51%
CALD Callidus Software Inc2.35%
BOFI BofI Holding Inc2.25%
INGN Inogen Inc2.10%
PGTI PGT Inc2.05%
LHCG LHC Group Inc2.02%
AHS AMN Healthcare Services Inc1.99%
-- 1.98%
ATRC AtriCure Inc1.89%

Partner Offers